Navigation Links
HTRF IP-One Assay Performed on the PHERAstar and RUBYstar Plate Readers

himeric constructs. There is a strong correlation with reference methods and no cross reactivity with 50 M of the following (phospho) inositides phosphates could be observed: Myo-inositol, PIP2, PIP3, IP2, IP3 and IP4.

In addition, for a direct performance comparison of BMG LABTECHs PHERAstar with the RUBYstar the IP-One assay was applied upon the 1321N1-CCK1 cell line together with the agonist CCK8-sulfated. The experiment was performed in 96-well plates resulting in very close EC50 values and a very good correlation regarding the %inhibition / basal curve (figure 3). Z' calculations at an agonist concentration equal to EC80 resulted in Z' > 0.78 for both plate readers.


But reaching beyond these expected results, the IP-One assay has already proved its worth in the field of screening for inverse agonist compounds. Looked at closely, and given its transitory characteristics, calcium measurement is often not sensitive enough to specifically detect the inhibition of the GPCR constitutive activities, whereas a modulation in the concentration of IP1 is perfectly able to show this. Using the IP-One assay therefore represents a tempting new alternative when investigating Gq-coupled receptors via the quantification of a new secondary messenger for this pathway, IP1. The messengers stability opens the possibility of the IP-One assays application to cases where other HTS technologies fail to provide a satisfactory solution such as in the detection of inverse agonist activities. The assay also profits from the special qualities of d2, one of the latest improvements implemented in HTRF technology. Given its performance, d2 is now included in all HTRF<
'"/>

Source:


Page: All 1 2 3 4 5 6

Related biology technology :

1. A Positive Selection Assay for Mutation Analysis in Big Blue Animals
2. Luminol-enhanced Assay for Superoxide Anion (O2 face="Symbol" )
3. Organize Your Data from the Big Blue Mutation Assay
4. Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations
5. RNase Protection Assay (RPA) Using DIG-Labeled RNA Probes
6. measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay
7. Matched siRNAs and Assays: Ambion + Applied Biosystems = RNAi Success
8. Using Validated siRNAs in Functional Genomic Assays
9. Nuclease Protection Assays: The Basics
10. RNArticles: RNA Amplification Used to Develop a New In Vitro HCMV Assay
11. Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: HTRF One Assay Performed the PHERAstar and RUBYstar Plate Readers

(Date:12/24/2014)... LOUIS , Dec. 23, 2014 ... today that the waiting period under the Hart-Scott-Rodino ... the acquisition expired on December 22, 2014, thereby ... review requirement for the acquisition of the Company ... U.S. antitrust clearance satisfies another condition to closing ...
(Date:12/22/2014)... /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: ... the development of autologous cell therapies, announced today the ... Calgary in conjunction with co-authors from Kyoto University and ... company,s ongoing clinical research using dermal sheath cup (DSC) ... The paper entitled " Hair Follicle Dermal Stem ...
(Date:12/22/2014)... 22, 2014 ITRA Global, one of ... of commercial real estate, has further expanded its global ... Perth and Brisbane, Western Australia, reports Mylinda Vick, CCIM, ... ITRA Global / ACORPP (Australian Corporate Property and ... company providing property services to a wide range of ...
(Date:12/19/2014)... 19, 2014 Naurex Inc., a biopharmaceutical company ... diseases of the central nervous system, today announced that ... officer, will present at the 33 rd annual ... place at 3:00 p.m. PST on Tuesday, January 13, ... San Francisco, Calif. About ...
Breaking Biology Technology:Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2
... , ATLANTA and LONDON, Sept. 10 ... biological medical device and cardiovascular tissue processing company, today announced the ... Matrix, which received CE mark approval in August 2009. BioFoam was ... supplemental measure to promote hemostasis (a complex process that stops bleeding) ...
... WATERTOWN, Mass., Sept. 10 Tetraphase Pharmaceuticals ... technology announced today that it will present three (3) ... and antibacterial activity of analogs from several novel classes ... Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in ...
... BALTIMORE, Sept. 10 Champions Biotechnology, Inc. ... oncology services division assists physicians by providing personalized treatment options ... with PinnacleCare , the pioneer and the ... , PinnacleCare will offer Champions, personalized oncology services ...
Cached Biology Technology:CryoLife Announces First Clinical Use of BioFoam(R) 2CryoLife Announces First Clinical Use of BioFoam(R) 3CryoLife Announces First Clinical Use of BioFoam(R) 4CryoLife Announces First Clinical Use of BioFoam(R) 5Tetraphase Presents Study Results for Novel Classes of Antibiotics from its Breakthrough Synthetic Chemistry Platform at ICAAC 2009 2Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 2Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 3Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 4
(Date:12/17/2014)... N.C. , Dec. 16, 2014 Valencell, ... licensed its PerformTek biometric technology to industry leaders such ... highly accurate, clinically validated, biometric wearable products. These products ... 6-9 in Las Vegas . ... technology is accurate, flexible and robust – with the ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research ... http://photos.prnewswire.com/prnh/20130307/600769 ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) ... Market in the APAC Region 2015-2019"  report to ... emerging in this market is advances in technology. ... to upgrade biometric solutions to the latest standard ...
(Date:12/10/2014)... You,ve been here before: you desperately need to sign into ... key or the answer to your secret question. What,s your ... Today, Hoyos Labs , a digital infrastructure security ... an end to the frustration that comes with usernames, passwords ... a user,s smartphone to acquire his or her biometrics to ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
... July 23, 2013 The goal of smart cities ... performance, efficiency and functionality. This is expressed through an ... of the overall city experience.  Cities are hoping to ... city projects to ultimately drive economic growth. Some key ...
... in the July issue of the Journal of ... super-infections like pneumonia with influenza. The research was led ... infectious disease specialist who is also chair of the ... Science Center and adjunct faculty at St. Jude Children,s ...
... NY. -- The use of central nervous system fetal ... cells for transplantation procedures aimed at restoring damage done ... tissue microbial contaminants have been known to cause brain ... team from Germany has developed a "washing" technique that ...
Cached Biology News:Frost & Sullivan: Moving the Smart Cities Idea from Concept to Reality 2Frost & Sullivan: Moving the Smart Cities Idea from Concept to Reality 3Frost & Sullivan: Moving the Smart Cities Idea from Concept to Reality 4Frost & Sullivan: Moving the Smart Cities Idea from Concept to Reality 5New protocol developed to decontaminate human fetal tissues used for cell transplantation 2
Edited by I.H. Pawlowitzki, J.H. Edwards and E.A. Thompson (1997) • This volume covers: Linkage in dominant recessive and oligogenic disease, Model free (non-parametric) methods, Tools for gene ...
... Cloning is the most ... cloning PCR products. TOPO ... Blunt TOPO vectors are ... with topoisomerase I. This ...
... TOPO Cloning is the ... for cloning PCR products. ... Zero Blunt TOPO vectors ... activated with topoisomerase I. ...
ready-to-use solution...
Biology Products: